Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis — BIGG  

Cat-Scratch Disease Clinical Trial

Official title: Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis: A Randomized Controlled Study

Status Recruiting

Clinical Trial Summary

To compare effect of intra-nodal injection of gentamicin versus placebo on the outcome at 28 days of suppurated cat scratch disease's (CSD) lymphadenitis treated by oral azithromycin.

Clinical Trial Description

Double blind controlled study versus placebo. Patients with suppurated CSD's lymphadenitis will receive immediately after the pus aspiration (performed for a diagnostic purpose) an intra-nodal injection of gentamicin or of placebo (NaCl 0,9%) and be treated with oral azithromycin for 5 days. ;

Related Conditions & MeSH terms

• Cat-Scratch Disease
• Lymphadenitis

• NCT number: NCT03132116
• Study type: Interventional
• Source: University Hospital, Toulouse
• Contact: Guillaume MARTIN-BLONDEL, MD, PhD
• Phone: +33 (0) 5 61 77 96 99
• Email: martin-blondel.g@chu-toulouse.fr
• Status: Recruiting
• Phase: Phase 3
• Start date: May 31, 2017
• Completion date: December 2023